April 25, 2018 11:22 AM ET


Company Overview of Xiamen Amoytop Biotech Co., Ltd.

Company Overview

Xiamen Amoytop Biotech Co., Ltd. offers research and development services for recombinant protein drugs. Its products include Molgramostim (rhGM-CSF), a recombinant human granulocyte macrophage colony stimulating factor; Filgrastim (rhG-CSF), a recombinant human granulocyte colony stimulating factor; and Oprelvekin (rhIL-11), a recombinant human interleukin 11. The company also provides active pharmaceutical ingredient (API) and reagents. It also offers clinical and pre-clinical studies. Xiamen Amoytop Biotech Co., Ltd. was founded in 1994 and is based in Xiamen, China.

No.330 Wengjiao Road

Xinyang Industry Zone of Haicang

Xiamen,  361022


Founded in 1994


86 59 2688 9106


86 59 2688 9110

Key Executives for Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech Co., Ltd. does not have any Key Executives recorded.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xiamen Amoytop Biotech Co., Ltd., please visit www.amoytop.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.